Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,102.61
(
-0.33%
)
US TECH 100
25,853.20
(
-0.39%
)
Dow Jones
49,397.28
(
-0.10%
)
Brent Oil
91.45
(
-1.31%
)
Bitcoin
76,264.02
(
3.25%
)
News Focus
News Focus
Post# of 257430
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122879
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: RNsidersbuying post# 241893

Saturday, 04/02/2022 2:43:24 PM

Saturday, April 02, 2022 2:43:24 PM

Post# of 257430

…SBTX could close their doors today - and issue some $7+ to all shareholders...or a healthy double from Friday's close?

Regrettably, that kind of shareholder-friendly resolution to a failed business plan hardly ever happens in the biotech sector. Going back almost 20 years, I can recall only one instance: CABG Medical (#msg-10880880, see bottommost paragraph).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today